23andMe and GSK Head to Clinical Trials With Cancer Drug

(Bloomberg) -- U.K. drugmaker GlaxoSmithKline Plc and genetic-testing giant 23andMe Inc. have begun their first joint human clinical trial as part of a collaboration to leverage the Silicon Valley ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.